| 2026-02-24 | UPC_CFI_337/2025 | Munich CD | Revocation Action | Revocation merits | Patent maintained | The Central Division (Munich) dismissed TCL Europe's revocation action against Corning's EP 3 296 274 (glass composition), finding all invalidity attacks unsuccessful. The patent was maintained as granted; TCL was ordered to bear Corning's legal costs. |
| 2026-02-24 | UPC_CFI_829/2024 | Munich CD | Revocation Action | Revocation merits | Revoked | The Central Division (Munich) revoked EP 2 611 800 (sugar compositions) in its entirety for Austria, Finland, France, Germany, Netherlands and Sweden, finding the claims lacked inventive step and the application to amend was dismissed. The defendant bears UPM's costs. |
| 2025-12-01 | UPC_CFI_337/2025 | Munich CD | Revocation Action | Procedural | Procedural only | The Central Division (Section Munich) judge-rapporteur issued a Rule 105.5 interim conference order in the revocation action concerning EP 3 296 274, setting procedural timetable, case valuation, and directions for further submissions including responses to an expert opinion. |
| 2025-11-21 | UPC_CFI_829/2024 | Munich CD | Revocation Action | Procedural | Procedural only | The Central Division (Munich) issued an order following the interim conference under Rule 105.5 RoP in UPM-Kymmene's revocation action against International N&H Denmark ApS, setting the case value at EUR 1,000,000 and confirming the oral hearing date of 15 January 2026. |
| 2025-11-20 | UPC_CFI_836/2024 | Munich CD | Revocation Action | Revocation merits | Partially revoked | The Munich Central Division partially revoked EP 4 019 790 B1 for 17 Member States in revocation proceedings brought by BAUSSMANN against Raimund Beck, upholding the patent only as amended per Auxiliary Request III (with claims 5 and 6 unchanged), and dismissing the remaining revocation claim; costs were split 70/30 in favour of the claimant. |
| 2025-10-10 | UPC_CFI_280/2025 | Munich CD | Revocation Action | Procedural | Procedural only | The Central Division Munich (judge-rapporteur Kupecz) issued an order following the interim conference in the Wirplast v Vilpe revocation action concerning EP 2 649 380, permitting the defendant to re-order its auxiliary requests and setting procedural deadlines. |
| 2025-04-18 | UPC_CFI_526/2024 | Munich CD | Generic Order | — | Procedural only | Case management order in a revocation action. The court noted the written pleadings have been exchanged and set the further procedural steps. The claimant seeks full revocation of EP 3 767 151; the defendant seeks dismissal and, in the alternative, maintenance of the patent in amended form across 80 auxiliary requests. |
| 2024-10-22 | UPC_CFI_1/2023 | Munich CD | Application RoP262.1 (b) | Procedural | Procedural only | Munich Central Division granted Dehns' (a UPC representative firm) request for access to written pleadings and evidence in the concluded Sanofi v. Amgen revocation proceedings under R.262.1(b) RoP. The Court found that since proceedings had concluded, the balance of interests normally favours granting access to third parties with a legitimate general interest. |
| 2024-07-23 | UPC_CFI_75/2023 | Munich CD | Generic application | Procedural | Settled | Order from the Munich Central Division (Section) dated 23 July 2024 disposing of two revocation actions brought by Astellas Institute for Regenerative Medicine against Healios K.K., Riken and Osaka University. Both parties submitted a unanimous application under R. 360 RoP declaring that they concluded the actions by settlement and that the actions were devoid of purpose. The court held that parties may settle without seeking a confirmatory court decision under R. 365 RoP and declared the proceedings closed. A 20% reimbursement of court fees was granted under R. 370.9(c) RoP. Headnotes clarify that settlement-based closures are not limited to the formal R. 365 confirmation procedure. |
| 2024-07-16 | CC_586764/2023 | Munich CD | Counterclaim for revocation | Revocation merits | Revoked | The patent EP 3 666 797 B1 was revoked in its entirety for all Contracting Member States in which revocation was requested. The Main Request and all 17 Auxiliary Requests were found to lack inventive step. The defendant (patent proprietor Amgen) was ordered to bear the claimant's legal costs, agreed at EUR 1.375 million. |
| 2024-07-16 | UPC_CFI_1/2023 | Munich CD | Revocation Action | Revocation merits | Revoked | The Munich Central Division (UPC's first-ever revocation case) revoked European patent EP 3 666 797 B1 (relating to an anti-PCSK9 antibody composition for treating hypercholesterolaemia, owned by Amgen) in its entirety for the territories of 17 UPC Contracting Member States. The patent was found to lack inventive step. All 17 auxiliary requests were also found to lack inventive step. Amgen (defendant/patent proprietor) was ordered to bear Sanofi's legal costs of EUR 1,375,000. |
| 2024-03-18 | UPC_CFI_75/2023 | Munich CD | Revocation Action | Procedural | Procedural only | The Munich Central Division judge-rapporteur issued an interim conference order (R. 105.5 RoP) in the revocation action brought by Astellas Institute against Healios, Riken, and Osaka University concerning EP 3 056 563. The order recorded decisions taken at the interim conference to prepare for the oral hearing, including procedural directions on evidence and scheduling. |
| 2024-03-18 | UPC_CFI_80/2023 | Munich CD | Revocation Action | Procedural | Procedural only | Order following the interim conference (R. 105.5 RoP) in the revocation action by Astellas Institute for Regenerative Medicine against Healios K.K. and Osaka University (EP 3 056 564) at the Munich Section of the Central Division. The court confirmed the oral hearing would proceed as planned and admitted a second expert declaration (D21) conditionally, giving the defendant limited time to reply. |
| 2024-02-24 | UPC_CFI_1/2023 | Munich CD | Revocation Action | Procedural | Procedural only | The Munich Central Division issued a procedural order combining two related revocation actions (Sanofi v Amgen and Regeneron v Amgen) into a single proceeding, admitted additional documents into evidence, rejected a request for an interim conference, and set the value of each action at EUR 100 million. |
| 2024-01-24 | UPC_CFI_1/2023 | Munich CD | Revocation Action | Procedural | Procedural only | The Munich Central Division judge-rapporteur issued a procedural order in the Sanofi v. Amgen revocation action, declining Sanofi's request to admit supplementary expert declarations filed in response to new points raised in Amgen's rejoinder, noting that the proper course was to raise the matter at the upcoming interim conference. |
| 2023-11-20 | UPC_CFI_80/2023 | Munich CD | Revocation Action | Procedural | Procedural only | The Munich Central Division refused a request by Healios K.K. and Osaka University to stay UPC revocation proceedings pending a decision by the EPO, finding no concrete near-future date for an EPO decision and holding that the interests of the parties must be weighed, with the claimant's interest in timely proceedings prevailing. |
| 2023-11-17 | UPC_CFI_80/2023 | Munich CD | Revocation Action | Procedural | Procedural only | The Munich Central Division issued an order on a Rule 262A application by Astellas Institute for Regenerative Medicine to restrict access to a confidential annex, addressing the scope of access permitted to named individuals at the defendant entities Healios K.K. and Osaka University in the revocation action concerning EP 3 056 564. |
| 2023-10-30 | UPC_CFI_252/2023 | Munich CD | Revocation Action | Procedural | Procedural only | The Munich Central Division ordered Harvard College (claimant/defendant in revocation action) to provide security for legal costs under Article 69(4) UPCA and Rule 158 RoP, finding legitimate concern about enforcement of a potential cost order against NanoString Technologies Europe (a UK-based entity) in light of a preliminary injunction already imposed. |
| 2023-10-11 | UPC_CFI_75/2023 | Munich CD | Revocation Action | Procedural | Procedural only | The Munich Central Division issued a Rule 9 RoP procedural order directing parties to use the CMS and designated workflows for all submissions, clarifying that system-generated notifications constitute electronic service under Rules 278.1 and 271.6 RoP, in the revocation action by Astellas. |
| 2023-10-11 | UPC_CFI_80/2023 | Munich CD | Revocation Action | Procedural | Procedural only | The Munich Central Division issued a Rule 9 RoP procedural order directing parties to use the CMS and designated workflows for all submissions and limiting external correspondence to a minimum, in the revocation action by Astellas against Healios K.K. and Osaka University. |
| 2023-10-04 | UPC_CFI_252/2023 | Munich CD | Revocation Action | Procedural | Procedural only | The Munich Central Division ordered that a preliminary objection based on Articles 29 and 30 Brussels Ibis Regulation (lis pendens / related actions) be dealt with in the main proceedings rather than separately, for reasons of procedural economy and efficiency under Rule 20.2 RoP. |
| 2023-09-21 | UPC_CFI_75/2023 | Munich CD | Revocation Action | Procedural | Procedural only | The Munich Central Division rejected a Rule 262.1(b) request for public access to written pleadings, holding that 'education and training' does not constitute a concrete and verifiable legitimate reason, and that there is no legal basis to grant access to a letter for service. |
| 2023-09-20 | UPC_CFI_1/2023 | Munich CD | Revocation Action | Revocation merits | Dismissed | The Munich Central Division rejected an anonymous individual's R. 262.1(b) RoP application for access to pleadings and evidence filed in Sanofi's revocation action against Amgen (EP patent, case UPC_CFI_1/2023), holding that a personal and professional interest in forming an opinion on patent validity is not a legitimate reason for granting third-party access to the case file. |
| 2023-08-24 | UPC_CFI_1/2023 | Munich CD | Preliminary objection | motionName.jurisdictional | Procedural only | The Central Division (Munich) rejected Amgen's preliminary objection challenging jurisdiction over Sanofi's revocation action, holding that the UPC Registry functions as a single receiving mailbox for the whole court and that the action was validly filed. |
| 2023-06-29 | UPC_CFI_1/2023 | Munich CD | Revocation Action | Procedural | Procedural only | The Central Division (Munich) issued a procedural order admitting Sanofi's supplementary exhibits to the Statement of Claim (filed via generic application) and confirming the date of service of the Statement for Revocation on Amgen. |